No More Eye Injections for Wet Macular Degeneration?

Genetech has formulated Lucentis’ active ingredient into a refillable eye implant that delivers the medication continuously into the eyes of wet macular degeneration patients. Known as the Port Delivery System, the implantable drug has shown promising results in the second phase of clinical studies. The Port Delivery System is slightly bigger than a grain of […]

Immune cells in retina play a role in vision loss

Australian researchers discovered that a mutation in immune cells (microglia) that exist in the retina prevent cones from developing properly. This discovery is the first time immune cells have been found to play a critical role in the development of cones and gives researchers a better understanding of macular degeneration and other genetic eye diseases. […]

How Did Woman Show Reversal of Macular Drusen?

One of the benefits of formulating macular degeneration supplements and being an eye physician who examines patients is that you can experience the fruits of your sleepless nights fretting about choosing the best natural ingredients that are based upon the latest scientific research. And so it was on Wednesday afternoon when my patient with extensive […]

Vision loss reversed with new stem cell therapy

A Phase 1 Clinical study of an experimental stem cell treatment for the web form of macular degeneration has resulted in two people having their vision loss reversed and their vision improving to being able to read with reading glasses. The study was published in Nature Biotechnology. Doctors used a surgical tool specifically designed for […]

Sex hormones affect eyes

A study published online in the Journal of Cellular Physiology suggests that fluctuations in sex steroid homeostatis may have a direct impact on eye physiology and on eye diseases such as age-related macular degeneration. Researchers from Temple University’s Sbarro Institute were looking to determine whether male gender can be considered a risk factor in developing age-related […]

Study compares Lucentis regimens for wet AMD

The treat-and-extend (TE) protocol of Lucentis (ranibizumab) is just as effective as a monthly regimen of ranibizumab when looking at increasing visual acuity in patients with neovascular age-related macular degeneration (AMD). The 12-month study was conducted in Portugal and led by Rufino Silvia, MD, PhD and involved 650 wet AMD patients aged 50 and older. […]

Fruit fly eyes helpful in understanding human blindness

Scientists have long understood that blue light will make fruit flies go blind but had been unable to determine why. A recent Purdue University study revealed how blue light kills cells in the eyes of the fruit fly and opens up the possibility of further understanding human eye diseases such as macular degeneration. Researchers compared […]

Women are #1 in Vision Problems

When it comes to problems with eyes and vision, more women than men are affected and the reason for this disparity is unknown. Worldwide statistics indicate that women account for two-thirds of the visually impaired or blind. In the United States, almost 2.7 million women over the age of 40 have low vision or are […]

BREAKTHROUGH – Blood test for Macular Degeneration?

Researchers at Massachusetts Eye and Ear have found that a particular set of metabolites in the blood are good markers for diagnosing AMD as well as indicating the severity of Macular Degeneration Metabolites, or breakdown products, are a result of both genes and environment. The “metabolome” — the set of metabolites present in an individual — […]

Effects of blue light exposure reduced with lutein and zeaxanthin

Benefits of lutein and zeaxanthin supplementation on blue-absorbing macular pigment, sleep quality and visual performance The results of the study were published in Foods. The macular carotenoids, lutein and zeaxanthin isomers, are known as high-energy blue light filters. Blue light penetrates deep into the eye and can cause the formation of free radicals. In the […]